drugset

drugset / Trial / NCT05795699

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05795699 ↗

Phase 3 Completed 107 enrolled Kowa Research Institute, Inc.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.

Timeline

Start: 2023-03-30
Primary completion: 2025-05-22
Completion: 2026-02-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ripasudil	Small molecule	—	Topical

Indications